In hepatocellular carcinoma and lung cancer cells, HSP70 promotes cancer progression by binding to TLR2 and to the receptor for advanced glycation end products (RAGE) and inducing MyD88-dependent and -independent NF-κB activation and pro-inflammatory gene transcription [108, 114]. Here, AGER is linked to lung carcinoma.